<DOC>
	<DOCNO>NCT00733135</DOCNO>
	<brief_summary>This multi-center , non-randomized , single arm study SilverHawk™ /TurboHawk™ plaque excision system use conjunction SpiderFX™ embolic protection device treatment moderate severely calcified peripheral arterial disease superficial femoral and/or popliteal artery .</brief_summary>
	<brief_title>Study SilverHawk™ /TurboHawk™ Plaque Excision Systems Used With SpiderFX Treat Calcified Peripheral Arterial Disease ( DEFINITIVE Ca++ )</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<criteria>Provides write informed consent Willing comply followup evaluation specify time Has leg pain due peripheral arterial disease Disease locate within femoropopliteal artery Moderate severe calcification Previously implant stent ( ) stent graft ( ) target leg Life expectancy le 12 month Has plan surgical endovascular intervention target vessel 30 day index procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>peripheral vascular disease</keyword>
	<keyword>atherectomy</keyword>
	<keyword>atherosclerosis</keyword>
	<keyword>calcify lesion</keyword>
</DOC>